Follow Appian to never miss an important update.
After Appian reported its November results, we updated our fair value. We moved our call from Buy to Watch. We raised our quality score to 4.0 as we increased our ratings for sales growth and how well the business holds up as artificial intelligence changes the industry. We added the company's new $83 million share repurchase program and the volatility of its litigation costs to what we track.
Appian earned $0.51 per share this quarter, well above the $0.33 analysts were looking for. Total revenue reached $234.6 million, a 25 percent jump from last year. The core cloud subscription business grew 20 percent, which is the specific target the company needs to hit to prove its transition to a profitable software-as-a-service model is working.
Existing customers are also spending more. The company’s net expansion rate hit 120 percent, meaning current clients increased their spending by 20 percent over the last year. This suggests that once a large organization builds its workflows on Appian’s platform, it tends to stick around and add more services. Operating income also rose to $21.3 million, showing that the company is successfully growing its sales without letting its own costs spiral out of control.
See the full quarter, and how our tracked metrics did
Source: 8-K filing
Appian's defense cloud platform earned Impact Level 5 authorization from the Department of War. This is the highest security level for unclassified data, meaning the company can now host more sensitive mission-critical information for military and government agencies.
This is a meaningful win for a software company because government contracts are typically long-term and very hard to cancel. Reaching this security tier makes it easier for Appian to win larger deals within the defense sector, where security requirements often block smaller rivals.
Source: PRNewsWire
The US Army launched the first version of a new munitions tracking system built on Appian's platform. The system was developed in 110 days and is designed to serve more than 10,000 users globally. This serves as a concrete example of Appian's "low-code" promise, which is the idea that large organizations can build complex software much faster than with traditional coding. Successfully launching a large-scale military project helps prove the platform can handle the most demanding corporate and government workloads.
Source: PRNewsWire
Appian is partnering with PSI CRO, a company that manages clinical trials for drug makers, to launch a new tool that uses AI to organize complex research tasks. The first project focuses on site selection, which is the process of finding the right hospitals and clinics to run medical studies across different countries.
This is a clear example of Appian's strategy to move beyond general software and into specific industries like healthcare. For a long-term owner, this matters because it shows the company's AI features are being used for high-stakes work where accuracy is critical. If Appian can prove its platform saves time in the heavily regulated world of drug development, it makes the software much harder for these large customers to replace.
Source: PRNewsWire
Management has consistently set a bar they can clear, beating profit targets for five straight quarters as the business grows faster than their own forecasts.
| Expectation | |
|---|---|
| EPS | $0.37 |
| Revenue | $228M |